Statin Use and Brain Volume Changes
Author Information
Author(s): Gentreau Mélissa, Miguet Maud, Affatato Oreste, Rukh Gull, Schiöth Helgi Birgir
Primary Institution: University of Uppsala
Hypothesis
What is the association between statin use and brain volumes in middle-aged and older adults?
Conclusion
Statin use is associated with higher white matter hyperintensity volumes and lower grey matter volumes over a 9-year period.
Supporting Evidence
- Statin users had a mean grey matter volume reduction of 1575 mm3.
- Statin use was associated with a 20% mediation effect by total serum cholesterol concentration.
- Statin users exhibited higher white matter hyperintensity volumes compared to non-users.
Takeaway
People who take statins may have smaller brain areas and more white matter damage over time.
Methodology
This cross-sectional study analyzed brain volumes using MRI in a large population-based sample, comparing statin users and non-users.
Potential Biases
Potential recall bias in self-reported health conditions.
Limitations
The study is cross-sectional and cannot establish causation; it also lacks detailed information on statin dosage and duration.
Participant Demographics
Participants were middle-aged and older adults from the UK Biobank, with a mean age of 60 years for statin users and 55 years for non-users.
Statistical Information
P-Value
<0.0001
Confidence Interval
−2358, −791 for grey matter volume
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website